请输入您要查询的百科知识：

　

词条 Bruton's tyrosine kinase
释义

  1. Function

  2. Clinical significance

      BTK inhibitors  

  3. Discovery

  4. Interactions

  5. See also

  6. References

  7. Further reading

  8. External links

{{Infobox_gene}}

Bruton's tyrosine kinase (abbreviated Btk or BTK) also known as tyrosine-protein kinase BTK is an enzyme that in humans is encoded by the BTK gene. BTK is a kinase that plays a crucial role in B-cell development.

Function

BTK plays a crucial role in B cell maturation as well as mast cell activation through the high-affinity IgE receptor.{{cn|date=November 2018}}

Btk contains a PH domain that binds phosphatidylinositol (3,4,5)-trisphosphate (PIP3). PIP3 binding induces Btk to phosphorylate phospholipase C, which in turn hydrolyzes PIP2, a phosphatidylinositol, into two second messengers, inositol triphosphate (IP3) and diacylglycerol (DAG), which then go on to modulate the activity of downstream proteins during B-cell signalling.{{cn|date=November 2018}}

Clinical significance

Mutations in the BTK gene are implicated in the primary immunodeficiency disease X-linked agammaglobulinemia (Bruton's agammaglobulinemia); sometimes abbreviated to XLA. Patients with XLA have normal pre-B cell populations in their bone marrow but these cells fail to mature and enter the circulation. The Btk gene is located on the X chromosome.[1] At least 400 mutations of the BTK gene have been identified.

BTK inhibitors

Approved drugs that inhibit BTK :

  • Ibrutinib (PCI-32765), a selective Bruton's tyrosine kinase inhibitor.
  • Acalabrutinib, approved in October 2017[2] for relapsed Mantle Cell Lymphoma

Various drugs that inhibit BTK are in clinical trials:[3]

  • Phase 3:
    • Acalabrutinib, for relapsed CLL, 95% overall remission reported.
  • Phase 2:
  • Phase 1:
    • ONO-4059 for Non-Hodgkin's Lymphoma and/or CLL.[4] Renamed GS-4059 and now in trial NCT02457598.[5]
    • spebrutinib (AVL-292, CC-292) [5]
    • BGB-3111 for CLL.[6] It can be taken orally.[7]
    • HM71224 for autoimmune diseases, under development by Hanmi Pharmaceutical and Lilly as of 2015[8]

Discovery

Bruton's tyrosine kinase was discovered in 1993 and is named for Ogden Bruton, who first described XLA in 1952.[1]

Interactions

Bruton's tyrosine kinase has been shown to interact with:

{{div col|colwidth=20em}}
  • ARID3A[9]
  • BLNK,[12][10]
  • CAV1,[11]
  • GNAQ,[12]
  • GTF2I,[13][14][15]
  • PLCG2,[16][17]
  • PRKD1,[18] and
  • SH3BP5.[19][20]
{{Div col end}}

See also

  • Ibrutinib (PCI-32765)
  • Acalabrutinib
{{Clear}}

References

1. ^1 X-Linked Agammaglobulinemia Patient and Family Handbook for The Primary Immune Diseases. Third Edition. 2001. Published by the Immune Deficiency Foundation.
2. ^https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm583076.htm
3. ^Astra Signals A Late Run On BTK Inhibition. Dec 2015
4. ^{{ClinicalTrialsGov|NCT01659255|ONO-4059 Phase I Dose-escalation Study to Investigate the Safety and Tolerability of ONO-4059 Given as Monotherapy in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma and/or Chronic Lymphocytic Leukaemi}}
5. ^{{ClinicalTrialsGov|NCT01351935|Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia}}
6. ^1 Novel BTK, PI3K Inhibitors on Horizon for Relapsed CLL. March 2016
7. ^BeiGene Announces Initiation of a Combination Trial of the BTK Inhibitor BGB-3111 with the PD-1 Antibody BGB-A317. June 2016
8. ^{{cite news|last1=Garde|first1=Damian|title=Lilly inks a $690M deal to get its hands on an autoimmune drug|url=http://www.fiercebiotech.com/r-d/lilly-inks-a-690m-deal-to-get-its-hands-on-an-autoimmune-drug|work=FierceBiotech|date=March 19, 2015|language=en}}
9. ^{{cite journal | vauthors = Nixon JC, Rajaiya JB, Ayers N, Evetts S, Webb CF | title = The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations | journal = Cell. Immunol. | volume = 228 | issue = 1 | pages = 42–53 | date = March 2004 | pmid = 15203319 | doi = 10.1016/j.cellimm.2004.03.004 }}
10. ^{{cite journal | vauthors = Hashimoto S, Iwamatsu A, Ishiai M, Okawa K, Yamadori T, Matsushita M, Baba Y, Kishimoto T, Kurosaki T, Tsukada S | title = Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling | journal = Blood | volume = 94 | issue = 7 | pages = 2357–64 | date = October 1999 | pmid = 10498607 | doi = }}
11. ^{{cite journal | vauthors = Vargas L, Nore BF, Berglof A, Heinonen JE, Mattsson PT, Smith CI, Mohamed AJ | title = Functional interaction of caveolin-1 with Bruton's tyrosine kinase and Bmx | journal = J. Biol. Chem. | volume = 277 | issue = 11 | pages = 9351–7 | date = March 2002 | pmid = 11751885 | doi = 10.1074/jbc.M108537200 }}
12. ^{{cite journal | vauthors = Ma YC, Huang XY | title = Identification of the binding site for Gqalpha on its effector Bruton's tyrosine kinase | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 95 | issue = 21 | pages = 12197–201 | date = October 1998 | pmid = 9770463 | pmc = 22808 | doi = 10.1073/pnas.95.21.12197 }}
13. ^{{cite journal | vauthors = Sacristán C, Tussié-Luna MI, Logan SM, Roy AL | title = Mechanism of Bruton's tyrosine kinase-mediated recruitment and regulation of TFII-I | journal = J. Biol. Chem. | volume = 279 | issue = 8 | pages = 7147–58 | date = February 2004 | pmid = 14623887 | doi = 10.1074/jbc.M303724200 }}
14. ^{{cite journal | vauthors = Novina CD, Kumar S, Bajpai U, Cheriyath V, Zhang K, Pillai S, Wortis HH, Roy AL | title = Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase | journal = Mol. Cell. Biol. | volume = 19 | issue = 7 | pages = 5014–24 | date = July 1999 | pmid = 10373551 | pmc = 84330 | doi = 10.1128/mcb.19.7.5014}}
15. ^{{cite journal | vauthors = Yang W, Desiderio S | title = BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 94 | issue = 2 | pages = 604–9 | date = January 1997 | pmid = 9012831 | pmc = 19560 | doi = 10.1073/pnas.94.2.604 }}
16. ^1 {{cite journal | vauthors = Yasuda T, Tezuka T, Maeda A, Inazu T, Yamanashi Y, Gu H, Kurosaki T, Yamamoto T | title = Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells | journal = J. Exp. Med. | volume = 196 | issue = 1 | pages = 51–63 | date = July 2002 | pmid = 12093870 | pmc = 2194016 | doi = 10.1084/jem.20020068 }}
17. ^{{cite journal | vauthors = Guo B, Kato RM, Garcia-Lloret M, Wahl MI, Rawlings DJ | title = Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex | journal = Immunity | volume = 13 | issue = 2 | pages = 243–53 | date = August 2000 | pmid = 10981967 | doi = 10.1016/s1074-7613(00)00024-8 }}
18. ^{{cite journal | vauthors = Johannes FJ, Hausser A, Storz P, Truckenmüller L, Link G, Kawakami T, Pfizenmaier K | title = Bruton's tyrosine kinase (Btk) associates with protein kinase C mu | journal = FEBS Lett. | volume = 461 | issue = 1-2 | pages = 68–72 | date = November 1999 | pmid = 10561498 | doi = 10.1016/S0014-5793(99)01424-6 }}
19. ^{{cite journal | vauthors = Matsushita M, Yamadori T, Kato S, Takemoto Y, Inazawa J, Baba Y, Hashimoto S, Sekine S, Arai S, Kunikata T, Kurimoto M, Kishimoto T, Tsukada S | title = Identification and characterization of a novel SH3-domain binding protein, Sab, which preferentially associates with Bruton's tyrosine kinase (BtK) | journal = Biochem. Biophys. Res. Commun. | volume = 245 | issue = 2 | pages = 337–43 | date = April 1998 | pmid = 9571151 | doi = 10.1006/bbrc.1998.8420 }}
20. ^{{cite journal | vauthors = Yamadori T, Baba Y, Matsushita M, Hashimoto S, Kurosaki M, Kurosaki T, Kishimoto T, Tsukada S | title = Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 96 | issue = 11 | pages = 6341–6 | date = May 1999 | pmid = 10339589 | pmc = 26883 | doi = 10.1073/pnas.96.11.6341 }}

Further reading

{{refbegin|35em}}
  • {{cite journal | vauthors = Ochs HD, Aruffo A | title = Advances in X-linked immunodeficiency diseases | journal = Curr. Opin. Pediatr. | volume = 5 | issue = 6 | pages = 684–91 | year = 1993 | pmid = 7907259 | doi = 10.1097/00008480-199312000-00008 }}
  • {{cite journal | vauthors = Uckun FM | title = Bruton's tyrosine kinase (BTK) as a dual-function regulator of apoptosis | journal = Biochem. Pharmacol. | volume = 56 | issue = 6 | pages = 683–91 | year = 1998 | pmid = 9751072 | doi = 10.1016/S0006-2952(98)00122-1 }}
  • {{cite journal | vauthors = Tsubata T, Wienands J | title = B cell signaling. Introduction | journal = Int. Rev. Immunol. | volume = 20 | issue = 6 | pages = 675–8 | year = 2001 | pmid = 11913944 | doi = 10.3109/08830180109045584 }}
  • {{cite journal | vauthors = Etzioni A | title = Novel aspects of hypogammaglobulinemic states | journal = Isr. Med. Assoc. J. | volume = 4 | issue = 4 | pages = 294–7 | year = 2002 | pmid = 12001708 | doi = }}
  • {{cite journal | vauthors = Niiro H, Clark EA | title = Branches of the B cell antigen receptor pathway are directed by protein conduits Bam32 and Carma1 | journal = Immunity | volume = 19 | issue = 5 | pages = 637–40 | year = 2003 | pmid = 14614850 | doi = 10.1016/S1074-7613(03)00303-0 }}
  • {{cite journal | vauthors = Carpenter CL | title = Btk-dependent regulation of phosphoinositide synthesis | journal = Biochem. Soc. Trans. | volume = 32 | issue = Pt 2 | pages = 326–9 | year = 2004 | pmid = 15046600 | doi = 10.1042/BST0320326 }}
  • {{cite journal | vauthors = Hendriks RW, Kersseboom R | title = Involvement of SLP-65 and Btk in tumor suppression and malignant transformation of pre-B cells | journal = Semin. Immunol. | volume = 18 | issue = 1 | pages = 67–76 | year = 2006 | pmid = 16300960 | doi = 10.1016/j.smim.2005.10.002 }}
{{refend}}

External links

  • [https://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=xla GeneReviews/NCBI/NIH/UW entry on X-Linked or Brunton's Agammaglobulinemia]
  • {{MeshName|Bruton's+tyrosine+kinase}}
  • {{UCSC gene info|BTK}}
{{PDB Gallery|geneid=695}}{{Tyrosine kinases}}{{Enzymes}}{{Portal bar|Molecular and Cellular Biology|border=no}}{{DEFAULTSORT:Bruton's Tyrosine Kinase}}

2 : Peripheral membrane proteins|Tyrosine kinases
随便看

　

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。

　

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间：2024/11/10 11:41:07